Cell ImpactOSTO:CI +0.43% EPS without NRI is kr-0.51 as of Mar. 2026. The stock has 7 warning signs investors should review. Among 2,419 Industrial Products companies, Cell Impact ranks better than 82.43% on this metric.
Cell Impact's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was kr-0.05.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.51.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 32.40% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -3.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Cell Impact's EPS without NRI or its related term are showing as below:
OSTO:CI'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -166.2 Med: -1.7 Max: 33.8
Current: 32.4
During the past 13 years, Cell Impact's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 33.80% per year. The lowest was -166.20% per year. And the median was -1.70% per year.
OSTO:CI's 3-Year EPS without NRI Growth Rate is ranked better than 82.43% of 2419
companies
in the Industrial Products industry
Industry Median: 3.5
vs OSTO:CI: 32.40
Cell Impact's EPS (Diluted) for the
three
months ended in Mar. 2026 was kr-0.05.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.51.
Cell Impact's EPS (Basic) for the
three
months ended in Mar. 2026 was kr-0.05.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.51.
Cell Impact (OSTO:CI) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Cell Impact EPS without NRI Related Terms
Cell Impact EPS without NRI Historical Data
* Premium members only.
The historical data trend for Cell Impact's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:CI vs CRS, ATI, MLI: EPS without NRI Comparison
For the Metal Fabrication subindustry, Cell Impact's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Impact PE Ratio without NRI vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Cell Impact's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Cell Impact's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.51
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Impact (OSTO:CI) has a EPS without NRI of kr-0.51 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cell Impact and its competitors. According to the industry distribution chart, Cell Impact ranks #425 out of 2419 companies in the Industrial Products industry, placing it in the top 17.6%.
Is Cell Impact's EPS without NRI too high?
Cell Impact's current EPS without NRI is kr-0.51. Based on the distribution chart, Cell Impact ranks #425 out of 2419 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers.
How does Cell Impact's EPS without NRI compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Cell Impact ranks #425 out of 2419 companies for EPS without NRI. This places Cell Impact in the top 18% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 3.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Industrial Products company?
The median EPS without NRI among Industrial Products companies is 3.50, based on 2,419 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cell Impact and its competitors. For the Industrial Products industry, the median EPS without NRI is 3.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Impact's current EPS without NRI is kr-0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (OSTO:CI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.07 — trading 41% above its estimated fair value. The current EPS without NRI is kr-0.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Cell Impact (OSTO:CI), the current EPS without NRI is kr-0.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:CI has been successfully added to your 